Desjardins Global Asset Management »

Regeneron Pharmaceuticals shares owned by Desjardins Global Asset Management

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Desjardins Global Asset Management from 13F filings

Historical chart of Desjardins Global Asset Management investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Desjardins Global Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Desjardins Global Asset Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $767k 873 878.15
2023-09-30 $1.1M 1.4k 822.91
2023-06-30 $1.6M 2.2k 718.54
2023-03-31 $2.3M 2.7k 821.56
2022-12-31 $2.7M 3.7k 721.26
2022-09-30 $3.4M 4.9k 688.72
2022-06-30 $2.9M 4.9k 591.02
2022-03-31 $4.0M 5.8k 698.32
2021-12-31 $5.9M 9.4k 631.43